Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

256.48
-1.9700-0.76%
Post-market: 256.770.2900+0.11%19:00 EDT
Volume:6.18M
Turnover:1.58B
Market Cap:617.94B
PE:29.70
High:257.80
Open:256.22
Low:251.95
Close:258.45
52wk High:281.07
52wk Low:184.66
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.77
T/O Rate:0.26%
Dividend:5.24
Dividend Rate:2.04%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:25.74%
ROA:8.59%
PB:7.27
PE(LYR):23.25

Loading ...

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Johnson & Johnson Schedules Investor Call to Discuss Third-Quarter Results

Reuters
·
Sep 01

Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says

MT Newswires Live
·
Aug 31

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

US FDA - Approves Stelara for Pediatric Ulcerative Colitis

THOMSON REUTERS
·
Aug 29

Lobe Sciences Names David Kideckel CFO as Mirza Rahimani Shifts to VP Finance

Reuters
·
Aug 28

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Reuters
·
Aug 27

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue

THOMSON REUTERS
·
Aug 27

Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)

TIPRANKS
·
Aug 26

Johnson & Johnson (JNJ) Wins FDA Approval For First Warm Autoimmune Hemolytic Anemia Treatment

Simply Wall St.
·
Aug 26

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Reuters
·
Aug 25

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

Reuters
·
Aug 25

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

Reuters
·
Aug 25

FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients

THOMSON REUTERS
·
Aug 25

Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet

TIPRANKS
·
Aug 22